METASTATIC MELANOMA
Clinical trials for METASTATIC MELANOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC MELANOMA trials appear
Sign up with your email to follow new studies for METASTATIC MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for advanced melanoma: immunotherapy combo tested in india
Disease control Not yet recruitingThis study tests a combination of two immunotherapy drugs (nivolumab and relatlimab) in 30 people in India with advanced melanoma that hasn't been treated before. The main goal is to check safety and side effects, and also to see how well the drugs shrink tumors. Participants wil…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE4 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Can a skin drug tame Immunotherapy's worst side effects?
Disease control Not yet recruitingThis small early study tests whether giving an IL-17 blocker (secukinumab) can safely reduce immune-related side effects in people with advanced melanoma who are restarting immunotherapy. Only 4 participants who previously had side effects like colitis or rash from checkpoint inh…
Matched conditions: METASTATIC MELANOMA
Phase: PHASE1 • Sponsor: Duke University • Aim: Disease control
Last updated May 07, 2026 18:49 UTC